Viral interference with B7-1 costimulation: A new role for murine cytomegalovirus Fc receptor-1

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8422-8431

  Mintern, Justine D ^a   Klemm, Elizabeth J ^a   Wagner, Markus ^a   Paquet, Marie Eve ^a   Napier, Melanie D ^a   Kim, You Me ^a   Koszinowski, Ulrich H ^b   Ploegh, Hidde L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; FC RECEPTOR; FC RECEPTOR 1; GLYCOPROTEIN 1; MEMBRANE PROTEIN; VIRUS PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CHO CELL; CONTROLLED STUDY; DENDRITIC CELL; GENE FUNCTION; GENE SEQUENCE; HERPES VIRUS; LYSOSOME; M138 GENE; MURINE CYTOMEGALOVIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRUS GENE; VIRUS INTERFERENCE;

EID: 33845437551     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8422     Document Type: Article

References (63)

1. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol. 8: 410-418.
2. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70: 8833-8849.
3. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and Their Replication. Lippincott Williams & Wilkins, Philadelphia.
4. Brune, W., M. Wagner, and M. Messerle. 2005. Manipulating cytomegalovirus genomes by BAC mutagenesis: strategies and applications. In Cytomegaloviruses: Molecular Biology and Immunology. M. J. Reddehase, ed. Caister Academic Press, Norwich.
5. Mocarski, E. S., Jr. 2002. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10: 332-339.
6. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
7. Sacre, K., G. Carcelain, N. Cassoux, A. M. Fillet, D. Costagliola, D. Vittecoq, D. Salmon, Z. Amoura, C. Katlama, and B. Autran. 2005. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201: 1999-2010.
8. Reddehase, M. J., F. Weiland, K. Munch, S. Jonjic, A. Luske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55: 264-273.
9. Polic, B., H. Hengel, A. Krmpotic, J. Trgovcich, I. Pavic, P. Luccaronin, S. Jonjic, and U. H. Koszinowski. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188: 1047-1054,
10. Jones, T. R., E. J. Wiertz, L. Sun, K. N. Fish, J. A. Nelson, and H. L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93: 11327-11333.
11. Ziegler, H., R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U. H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66.
12. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
13. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384: 432-438.
14. Reusch, U., W. Muranyi, P. Lucin, H. G. Burgert, H. Hengel, and U. H. Koszinowski. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18: 1081-1091.
15. Hewitt, E. W., S. S. Gupta, and P. J. Lehner. 2001. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20: 387-396.
16. Kavanagh, D. G., M. C. Gold, M. Wagner, U. H. Koszinowski, and A. B. Hill. 2001. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194: 967-978.
17. Lafferty, K. S., and J. Woolnough. 1977. The origin and mechanism of the allograft reaction. Immunol. Rev. 35: 231-262.
18. Bertram, E. M., W. Dawicki, and T. H. Watts. 2004. Role of T cell costimulation in anti-viral immunity. Semin. Immunol. 16: 185-196.
19. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. AnnU. Rev. Immunol. 23: 515-548.
20. Coscoy, L., and D. Ganem. 2001. A viral protein that selectively down-regulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107: 1599-1606.
21. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
22. Morrow, G., B. Slobedman, A. L. Cunningham, and A. Abendroth. 2003. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol. 77: 4950-4959.
23. Engelmayer, J., M. Larsson, M. Subklewe, A. Chahroudi, W. I. Cox, R. M. Steinman, and N. Bhardwaj. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163: 6762-6768.
24. Majumder, B., M. L. Janket, E. A. Schafer, K. Schaubert, X. L. Huang, J. Kan-Mitchell, C. R. Rinaldo, Jr., and V. Ayyavoo. 2005. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J. Virol. 79: 7990-8003.
25. Loewendorf, A., C. Kruger, E. M. Borst, M. Wagner, U. Just, and M. Messerle. 2004. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78: 13062-13071.
26. + cytotoxic T lymphocytes. Eur. J. Immunol. 26: 2595-2600.
27. Mutini, C., S. Falzoni, D. Ferrari, P. Chiozzi, A. Morelli, O. R. Baricordi, G. Collo, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1999. Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J. Immunol. 163: 1958-1965.
28. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158: 2723-2730.
29. Lutarewych, M. A., M. R. Quirk, B. A. Kringstad, W. Li, C. M. Verfaillie, and M. C. Jordan. 1997. Propagation and titration of murine cytomegalovirus in a continuous bone marrow-derived stromal cell line (M2-10B4). J. Virol. Methods 68: 193-198.
30. Freedman, A. S., G. Freeman, J. C. Horowitz, J. Daley, and L. M. Nadler. 1987. B7, a B-cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139: 3260-3267,
31. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89: 6020-6024.
32. Wang, Y. Q., A. Wada, S. Ugai, and M. Tagawa. 2003. Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects. Oncol. Rep. 10: 909-913.
33. Thale, R., P. Lucin, K. Schneider, M. Eggers, and U. H. Koszinowski. 1994. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68: 7757-7765.
34. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, et al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262: 907-909.
35. Bonifacino, J. S., and L. M. Traub. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72: 395-447.
36. Andrews, D. M., C. E. Andoniou, F. Granucci, P. Ricciardi-Castagnoli, and M. A. Degli-Esposti. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2: 1077-1084.
37. Moutaftsi, M., A. M. Mehl, L. K. Borysiewicz, and Z. Tabi. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99: 2913-2921.
38. Senechal, B., A. M. Boruchov, J. L. Reagan, D. N. Hart, and J. W. Young. 2004. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103: 4207-4215.
39. Mathys, S., T. Schroeder, J. Ellwart, U. H. Koszinowski, M. Messerle, and U. Just. 2003. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J. Infect. Dis. 187: 988-999.
40. Beck, K., U. Meyer-Konig, M. Weidmann, C. Nern, and F. T. Hufert. 2003. Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur. J. Immunol. 33: 1528-1538.
41. Henry, J., M. M. Miller, and P. Pontarotti. 1999. Structure and evolution of the extended B7 family. Immunol. Today 20: 285-288.
42. Stamper, C. C., Y. Zhang, J. F. Tobin, D. V. Erbe, S. Ikemizu, S. J. Davis, M. L. Stahl, J. Seehra, W. S. Somers, and L. Mosyak. 2001. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410: 608-611.
43. Ikemizu, S., R. J. Gilbert, J. A. Fennelly, A. V. Collins, K. Harlos, E. Y. Jones, D. I. Stuart, and S. J. Davis. 2000. Structure and dimerization of a soluble form of B7-1. Immunity 12: 51-60.
44. Schwartz, J. C., X. Zhang, A. A. Fedorov, S. G. Nathenson, and S. C. Almo. 2001. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410: 604-608.
45. Zhang, X., J. C. Schwartz, S. C. Almo, and S. G. Nathenson. 2003. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc. Natl. Acad. Sci. USA 100: 2586-2591.
46. Crnkovic-Mertens, I., M. Messerle, I. Milotic, U. Szepan, N. Kucic, A. Krmpotic, S. Jonjic, and U. H. Koszinowski. 1998. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72: 1377-1382.
47. + T cells and NK cells in vivo. Nat. Immunol. 3: 529-535.
48. Lodoen, M., K. Ogasawara, J. A. Hamerman, H. Arase, J. P. Houchins, E. S. Mocarski, and L. L. Lanier. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197: 1245-1253.
49. Lenac, T., M. Budt, J. Arapovic, M. Hasan, A. Zimmermann, H. Simic, A. Krmpotic, M. Messerle, Z. Ruzsics, U. H. Koszinowski, et al. 2006. The herpesviral Fc receptor fcr-I down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203: 1843-1850.
50. Dingwell, K. S., C. R. Brunetti, R. L. Hendricks, Q. Tang, M. Tang, A. J. Rainbow, and D. C. Johnson. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68: 834-845.
51. Dingwell, K. S., and D. C. Johnson. 1998. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J. Virol. 72: 8933-8942.
52. Card, J. P., M. E. Whealy, A. K. Robbins, and L. W. Enquist. 1992. Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J. Virol. 66: 3032-3041.
53. Doty, R. T., and E. A. Clark. 1996. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation. J. Immunol. 157: 3270-3279.
54. Doty, R. T., and E. A. Clark. 1998. Two regions in the CD80 cytoplasmic tail regulate CD80 redistribution and T cell costimulation. J. Immunol. 161: 2700-2707.
55. Suvas, S., V. Singh, S. Sahdev, H. Vohra, and J. N. Agrewala. 2002. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 277: 7766-7775.
56. Reiser, J., G. von Gersdorff, M. Loos, J. Oh, K. Asanuma, L. Giardino, M. P. Rastaldi, N. Calvaresi, H. Watanabe, K. Schwarz, et al. 2004. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 113: 1390-1397.
57. Wakem, P., R. P. Burns, Jr., F. Ramirez, D. Zlotnick, B. Ferbel, C. G. Haidaris, and A. A. Gaspari. 2000. Allergens and irritants transcriptionally up-regulate CD80 gene expression in human keratinocytes. J. Invest. Dermatol. 114: 1085-1092.
58. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5: 190-198.
59. Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J. M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2: 338-342.
60. Hudson, A. W., P. M. Howley, and H. L. Ploegh. 2001. A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol. 75: 12347-12358.
61. Piguet, V., F. Gu, M. Foti, N. Demaurex, J. Gruenberg, J. L. Carpentier, and D. Trono. 1999. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes. Cell 97: 63-73.
62. Mangasarian, A., V. Piguet, J. K. Wang, Y. L. Chen, and D. Trono. 1999. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal α helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73: 1964-1973.
63. Hudson, A. W., D. Blom, P. M. Howley, and H. L. Ploegh. 2003. The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 4: 824-837.